Pregnancy Clinical Trial
Official title:
A Community Trial to Measure the Effect of Individual Prenatal Education With Mobile Phone Consultations Offered to Pregnant Women in Masindi and Kiryandongo, Western Uganda
Introduction There is compelling evidence for scheduled home visits to improve newborn
health. There is also a growing wealth of evidence to support the use of mobile phones as a
public health tool in low and middle-income countries. UNICEF and WHO have recommended
implementation of home visits for newborn care improvement. In sub Saharan Africa the
evidence for a combined scheduled home visit and mobile phone technology to improve neonatal
health is lacking. In this study the investigators aim to determine the effect of scheduled
home visits by Community Health Workers (hereafter referred to as Village Health Teams-VHTs)
combined with mobile phone consultations on newborn care in Masindi, Uganda.
Methods This is a community intervention trial to be conducted in Masindi and Kiryandongo in
Uganda from May 2013 to June 2014. A mixed method data collection technique will be used.
Our overarching hypothesis is that survival of the newborn requires a continuum of care from
pregnancy to the newborn period. Eight health centres each will be randomly allocated to the
intervention arm and a control arm. Five villages will be randomly selected from each of the
catchment areas of the intervention health centres and one VHT purposively selected from
each of the villages. Intervention arm will receive VHTs equipped with mobile phones making
four scheduled home visits to women while the control arm will receive the standard care for
prenatal and immediate newborn education. VHTs will discuss care for the pregnancy, danger
signs in pregnancy, birth preparation, acquiring needed items for delivery and recommended
newborn care practices. VHTs can also make instant telephone consultations with the midwife
for a second opinion. A closed caller group for the mobile telephone consultation is already
negotiated with Mobile Telephone Network (MTN) a mobile phone service provider to allow
lower tariff rates. Our primary outcome variables of interest are hygienic cord care
(specifically application of substances on the cord), thermal care (specifically delayed
bathing of the baby soon after birth), initiation of breastfeeding within one hour and
avoiding pre-lacteal feeds. Secondary outcomes like completed four antenatal visits,
institutionalized delivery were also assessed.
Status | Recruiting |
Enrollment | 1 |
Est. completion date | September 2015 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - pregnant women with gestation of 28 weeks or less, making their first antenatal consultation Exclusion Criteria: - no exclusion criteria has been developed. All women that qualify are eligible for recruitment |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Uganda | Masindi | Masindi | Western Uganda |
Lead Sponsor | Collaborator |
---|---|
Makerere University | Institute of Tropical Medicine, Belgium |
Uganda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | birth preparedness | We will create a composite variable that will assess the level of birth preparedness based on primary variables mentioned in the protocol | 24 months | No |
Primary | delayed bathing of baby | We will measure the primary outcome of interest based on the number of days women delay to bathe their babies after delivery | 24 months | No |
Secondary | institutionalized delivery | Measure proportion of women who deliver their baby in a health centre | 24 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |